Seeking The Oracles

I’m seeing the respirologist on the 22nd to see if the lung fluid has finally lowered its volume or needs additional plumbing, followed by a chat with the oncologist on the 27th to see if the cancer is trying to find a clever workaround. The CT scan is on hold until March to allow the 'visual clutter' from the radiation to clear so the cameras can get a better look.

I shared these updates with my AI thought partner, which offered this perspective:

Based on your medical records and the provided oncology literature, Tagrisso (osimertinib) can still be effective systemically (throughout the rest of your body), even if a local mutation or resistance mechanism has developed in a specific area, such as the pleural fluid.
This clinical scenario is often referred to as oligoprogression—where the cancer grows in one or a few isolated spots while remaining controlled everywhere else.

At least the radiation therapy didn’t kill my sad sense of curiosity.